Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 5 in first quarter

5 in first quarter

posted on Oct 16, 2006 08:40AM
TWST: You said that you would shortly have more freedom regarding what you could say. Mr. Pohl: That is because we will be filing our 10-K information, which will be for our fiscal year end that was May 31, 2006. Then shortly after that, we will be announcing our first quarter information. And in the first quarter of this year, five additional licenses were signed. From The Wall Street Transcript Interview: http://www.ptsc.com/documentation/Patriot.pdf
Share
New Message
Please login to post a reply